Core Insights - The core viewpoint of the article emphasizes that Ruipai Pet Hospital's IPO application is not merely a capitalization of offline medical networks but signifies a profound industry insight, aiming to create a health management ecosystem for pets that integrates offline medical capabilities with digital solutions [1] Group 1: Industry Transformation - Traditional pet medical services are characterized as "passive, low-frequency, and scenario-based," leading to limited customer lifetime value (LTV). Ruipai's strategic transformation aims to shift this relationship to "active, high-frequency, and holistic" services [2] - Planned services will extend to smart online consultations, electronic prescription flows, remote health monitoring, customized health plans, and direct delivery of medications and nutritional products, enhancing customer engagement and interaction frequency [2] Group 2: Data Utilization - The deep value of the digital ecosystem lies in data accumulation, with each online consultation, follow-up purchase, and electronic health record contributing to a vast database on pet breeds, ages, health conditions, and consumption habits [3] - By leveraging AI and big data analytics, Ruipai aims to provide intelligent health management solutions, assist in diagnostic decisions, optimize treatment plans, and enhance marketing precision, evolving its business model from "medical service fees" to "technology empowerment fees" and "health management subscription fees" [3] Group 3: Operational Efficiency - Digitalization is crucial for Ruipai to solidify its offline foundation and address chain management challenges, enabling real-time monitoring and intelligent scheduling of procurement, treatment standards, financial processes, and customer satisfaction [4] - The unified digital platform supports the management of 548 offline hospitals and enhances operational efficiency, with an adjusted net profit of 72 million yuan in the first half of 2025, reinforcing its profitability [4] Group 4: Industry Collaboration - Ruipai is positioned to become a "platform-type" enterprise, integrating upstream and downstream industry players, including pharmaceutical companies, insurance providers, and smart hardware manufacturers, to create a comprehensive health service platform [5] - The IPO is seen as a strategic move to prepare for this ecosystem battle, marking a shift in competition from hospital numbers and doctor resources to ecosystem completeness, data richness, and platform collaboration capabilities [5] Group 5: Market Dynamics - The Chinese pet medical market is projected to grow from 36.6 billion yuan in 2024 to 139.2 billion yuan by 2035, with Ruipai's IPO representing a critical milestone in the industry's maturation [6] - Successful entry into the capital market not only expands Ruipai's development platform but also sets a benchmark for the industry, demonstrating a viable path to scale profitability through standardization and digitalization [7] - The transformation aligns with deeper industry needs, such as the younger, tech-savvy pet owners seeking convenience and intelligence, and the aging pet population requiring continuous, remote health interventions [7]

左医科技是业界领先的知识图谱和医疗大模型协同驱动的医疗科技公司。 本文为IPO早知道原创 作者｜ Stone Jin 微信公众号｜ipozaozhidao 2025年将是 AI 应用的爆发之年，这几乎已成为一种共识。 内唯一对标微软Nuance DAX的听译机器人，直接从医患沟通语音中生成病历 ； 2023年5月 ， 左 医科技率先发布医疗垂类大模型，并应用落地与四川省人民医院、北京天坛医院等百强医院，并助力 全国排名前三的儿科医院重庆医科大学附属儿童医院打造行业首个儿科医疗基座大模型。 此外， 左 医科技基于 multi-agent技术打造的AI医生，同宁夏中卫市、银川市、北京西城区卫健委签约，将 AI医生升级为AI家医作为现有家庭医生服务的有效补充。 截至目前， 左医科技打造的 "左手医生"品牌 已成为 国内领先的全科智能医生，提供 AI家庭医生、 智能导诊、预问诊、诊室听译机器人、智能在线问诊等解决方案，通过与不同应用场景的结合，提供 优质的医疗服务，赋能医疗健康行业，现已覆盖200余家三甲医院，其中超过40家为Top100医院。 在发布新一代 AI医疗 产品之际， 左医科技创始人 兼 CEO张超 向「 ...